Literature DB >> 25712567

Molecular damage and lung tumors in cigarette smoke-exposed mice.

Alberto Izzotti1, Alessandra Pulliero.   

Abstract

Cigarette smoke (CS) induces lung cancer through a multistep process that is now being depicted by molecular analyses. During the early phase (weeks), DNA damage occurs in nuclear and mitochondrial DNA, triggering adaptive responses activated by transient microRNA downregulation in the expression of defensive genes and proteins. During the intermediate phase (months), damaged cells are removed by apoptosis and the resulting cell loss is counteracted by a recruitment of stem cells that are highly sensitive to genotoxic damage. In parallel, microRNA downregulation becomes irreversible because of an accumulation of molecular damage in DICER. During the late phase (years), apoptosis efficacy is decreased by fragile histidine triad loss, while irreversible microRNA downregulation triggers the expression of mutated oncogenes, resulting in adenoma appearance. Furthermore, deletions occur in microRNA-encoding genes, causing carcinoma formation and uncontrolled growth. All reported pathogenic steps are required to obtain a fully developed lung cancer. This complex pathogenesis develops over a long period of time; therefore, it is difficult to induce cancer in short-living animals exposed to CS, whereas in humans there is a long latency from the start of smoke exposure to the onset of cancer.
© 2015 New York Academy of Sciences.

Entities:  

Keywords:  DNA damage; carcinogenesis; cigarette smoke; lung cancer; microRNA; mutation

Mesh:

Substances:

Year:  2015        PMID: 25712567     DOI: 10.1111/nyas.12697

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  11 in total

1.  The impact of smoking status on radiologic tumor progression patterns and response to epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitors in lung adenocarcinoma with activating EGFR mutations.

Authors:  Yoon Ki Cha; Ho Yun Lee; Myung-Ju Ahn; Keunchil Park; Jin Seok Ahn; Jong-Mu Sun; Yoon-La Choi; Kyung Soo Lee
Journal:  J Thorac Dis       Date:  2016-11       Impact factor: 2.895

Review 2.  A potential role for estrogen in cigarette smoke-induced microRNA alterations and lung cancer.

Authors:  Amit Cohen; Mario Alberto Burgos-Aceves; Yoav Smith
Journal:  Transl Lung Cancer Res       Date:  2016-06

3.  Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators.

Authors:  Marta Geretto; Alessandra Pulliero; Camillo Rosano; Dinara Zhabayeva; Rakhmet Bersimbaev; Alberto Izzotti
Journal:  Am J Cancer Res       Date:  2017-06-01       Impact factor: 6.166

Review 4.  Association of Smoking, Alcohol Use, and Betel Quid Chewing with Epigenetic Aberrations in Cancers.

Authors:  Tong-Hong Wang; Shih-Min Hsia; Yin-Hwa Shih; Tzong-Ming Shieh
Journal:  Int J Mol Sci       Date:  2017-06-06       Impact factor: 5.923

5.  Blood and lung microRNAs as biomarkers of pulmonary tumorigenesis in cigarette smoke-exposed mice.

Authors:  Alberto Izzotti; Roumen Balansky; Gancho Ganchev; Marietta Iltcheva; Mariagrazia Longobardi; Alessandra Pulliero; Marta Geretto; Rosanna T Micale; Sebastiano La Maestra; Mark Steven Miller; Vernon E Steele; Silvio De Flora
Journal:  Oncotarget       Date:  2016-12-20

6.  MiR-216b/Smad3/BCL-2 Axis Is Involved in Smoking-Mediated Drug Resistance in Non-Small Cell Lung Cancer.

Authors:  Trung Vu; Shanzhong Yang; Pran K Datta
Journal:  Cancers (Basel)       Date:  2020-07-13       Impact factor: 6.639

7.  Relationship between the miRNA Profiles and Oncogene Mutations in Non-Smoker Lung Cancer. Relevance for Lung Cancer Personalized Screenings and Treatments.

Authors:  Alberto Izzotti; Gabriela Coronel Vargas; Alessandra Pulliero; Simona Coco; Irene Vanni; Cristina Colarossi; Giuseppina Blanco; Antonella Agodi; Martina Barchitta; Andrea Maugeri; Gea Oliveri Conti; Margherita Ferrante; Salvatore Sciacca
Journal:  J Pers Med       Date:  2021-03-05

8.  Electronic Cigarette Smoke Impairs Normal Mesenchymal Stem Cell Differentiation.

Authors:  A Shaito; J Saliba; A Husari; M El-Harakeh; H Chhouri; Y Hashem; A Shihadeh; M El-Sabban
Journal:  Sci Rep       Date:  2017-10-27       Impact factor: 4.379

Review 9.  DNA Hydroxymethylation at the Interface of the Environment and Nonalcoholic Fatty Liver Disease.

Authors:  Stella Tommasi; Ahmad Besaratinia
Journal:  Int J Environ Res Public Health       Date:  2019-08-05       Impact factor: 3.390

10.  TRIM21 Polymorphisms are associated with Susceptibility and Clinical Status of Oral Squamous Cell Carcinoma patients.

Authors:  Chun-Yi Chuang; Yi-Chung Chien; Chiao-Wen Lin; Chia-Hsuan Chou; Shuo-Chueh Chen; Chun-Lin Liu; Li-Yuan Bai; Shun-Fa Yang; Yung-Luen Yu
Journal:  Int J Med Sci       Date:  2021-06-11       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.